Cytheris, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.cytheris.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant
Phase 1
Completed
- Conditions
- AMLCMLMDS
- Interventions
- Drug: CYT107 - Recombinant glycosylated human interleukin 7.Drug: rhIL-7 (CYT107)
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2012-07-26
- Lead Sponsor
- Cytheris, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00684008
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Institute, New York, New York, United States
News
No news found